Open-angle Glaucoma
📧 Sign up to get email alerts when something new happens for Open-angle Glaucoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: Prevalence of Obstructive Sleep Apnoea in Glaucoma
A completed clinical trial update reporting the prevalence of obstructive sleep apnea among patients with open-angle glaucoma.
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: A Study Assessing the Safety and Efficacy of DE-117 in Subjects With POAG or OH Who Are Non-/Low-responders to Latanoprost: FUJI Study [Phase 3]
Phase 3 FUJI study assessing the safety and efficacy of DE-117 in primary open-angle glaucoma or ocular hypertension patients who are non- o…
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: A Long-term Study of DE-117 Ophthalmic Solution Monotherapy and Concomitant Use of DE-117 Ophthalmic Solution With Timolol Ophthalmic Solution in Patients With OAG or OH: RENGE Study [Phase 3]
Phase 3 long-term study of DE-117 ophthalmic solution, used alone and with timolol, in open-angle glaucoma or ocular hypertension has comple…
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: A Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension -AYAME Study- [Phase 2, Phase 3]
This clinical trial update reports the completion of a Phase 2/3 study evaluating the efficacy and safety of DE-117 ophthalmic solution in a…
-
CLINICAL_TRIALS trial_result · 2017-11-08Clinical Trial Update: Efficacy and Tolerability of an Innovative Formulation of BAK-free Latanoprost [Phase 4]
A Phase 4 trial evaluated the efficacy and tolerability of a benzalkonium chloride-free (BAK-free) formulation of latanoprost in primary ope…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-11-02FDA Approved: VYZULTA — Original Application (Bausch & Lomb Incorporated)
FDA approved VYZULTA (latanoprostene bunod), from Bausch & Lomb, as a new treatment for open-angle glaucoma and ocular hypertension.
-
CLINICAL_TRIALS research · 2017-10-24Clinical Trial Update: LSFG in Patients With Normal Tension Glaucoma Tension Glaucoma [NA]
Clinical trial update for LSFG in patients with normal tension glaucoma, with primary open-angle glaucoma listed among the conditions; the s…
-
FDA label_change · 2017-09-22FDA Approved: TRAVATAN Z — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for TRAVATAN Z (travoprost) from Novartis Pharmaceuticals Corporation, resulting in updated labe…
-
CLINICAL_TRIALS trial_result · 2017-09-07Clinical Trial Update: Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimonidine BID in Subjects With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT) [Phase 3]
A Phase 3 trial evaluated the efficacy and safety of a fixed-dose combination of brinzolamide and brimonidine given twice daily versus separ…
-
CLINICAL_TRIALS trial_result · 2017-08-31Clinical Trial Update: A Three Part Study of MGV354 in Ocular Hypertension or Glaucoma [Phase 1, Phase 2]
Clinical trial update on MGV354 in ocular hypertension and open-angle glaucoma across Phase 1 and Phase 2. The results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-08-30Clinical Trial Update: Scleral Response to Intraocular Pressure (IOP)
The clinical trial evaluating scleral response to intraocular pressure in open-angle glaucoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-23Clinical Trial Update: A Study on the Effect of Changing From Preserved Prostaglandin Formulations to Preservative Free Tafluprost on Tear Film Thickness [Phase 4]
Phase 4 study evaluating tear film thickness after switching from preserved prostaglandin formulations to preservative-free tafluprost; the …
-
CLINICAL_TRIALS trial_result · 2017-07-26Clinical Trial Update: A Comparison of Xalatan (Latanoprost) to Apo-latanoprost and Co-latanoprost in the Treatment of Glaucoma [Phase 4]
This Phase 4 clinical trial update compares Xalatan (latanoprost) with Apo-latanoprost and Co-latanoprost for glaucoma and ocular hypertensi…
-
CLINICAL_TRIALS trial_result · 2017-07-25Clinical Trial Update: Efficacy of the Brand-name Latanoprost and One of Its Generic Version in Primary Open Angle Glaucoma and Ocular Hypertension [Phase 4]
Phase 4 trial evaluating the efficacy of brand-name latanoprost versus a generic latanoprost in primary open-angle glaucoma and ocular hyper…
-
CLINICAL_TRIALS research · 2017-07-21Clinical Trial Update: Effectiveness and Safety of Adipose-Derived Regenerative Cells for Treatment of Glaucomatous Neurodegeneration [Phase 1, Phase 2]
A phase 1/2 clinical trial update evaluating adipose-derived regenerative cells for glaucomatous neurodegeneration, including retinal degene…
-
CLINICAL_TRIALS research · 2017-07-21Clinical Trial Update: Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily [Phase 2]
An exploratory Phase 2 trial comparing D565H twice daily versus D565 once daily for open-angle glaucoma and ocular hypertension. The documen…
-
CLINICAL_TRIALS trial_result · 2017-07-18Clinical Trial Update: Comparison of Vitamin D Status and Vitamin D Receptor Polymorphisms in Patients With High Myopia and Primary Open-angle Glaucoma
The document reports the completion of a clinical trial comparing vitamin D status and vitamin D receptor polymorphisms in patients with hig…
-
FDA approval · 2017-07-07FDA Approved: TRAVOPROST OPHTHALMIC SOLUTION, 0.004% — Original Application (Mylan Pharmaceuticals Inc.)
FDA approves Mylan's travoprost ophthalmic solution 0.004% through an original application for lowering intraocular pressure in open-angle g…
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Efficacy and Safety of the ExPRESS Implant Versus Deep Sclerectomy in Combined Surgery [NA]
This clinical trial update reports on the efficacy and safety outcomes comparing the ExPRESS implant with deep sclerectomy in combined glauc…
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: Oculusgen (Ologen) Glaucoma MMC Control in Estonia [Phase 3]
Phase 3 clinical trial of Oculusgen (Ologen) collagen matrix for glaucoma completed in Estonia, evaluating several glaucoma subtypes.
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: Selective Laser Trabeculoplasty After Failed Phacoemulsification With Eximer Laser Trabeculectomy [NA]
Clinical trial update reporting results for selective laser trabeculoplasty after failed phacoemulsification with excimer laser trabeculecto…
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: AqueSys XEN 45 Glaucoma Implant in Refractory Glaucoma [NA]
This report summarizes a completed clinical trial evaluating the AqueSys XEN 45 glaucoma implant for refractory glaucoma, with results poste…
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Changes in Choroidal Thickness After Non Penetrating Deep Sclerectomy
A clinical trial update examining changes in choroidal thickness after non-penetrating deep sclerectomy in open-angle glaucoma.
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: CyPass Clinical Experience Study
The CyPass Clinical Experience Study sponsored by Transcend Medical has completed. It reports clinical experience data in open-angle glaucom…
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Divided Dose of TRAVATAN® [Phase 2]
Phase 2 trial evaluating divided dosing of TRAVATAN for open-angle glaucoma and ocular hypertension has completed.